These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


214 related items for PubMed ID: 10595659

  • 1. Evidence for antiphospholipid antibodies in hemophilic children with factor VIII inhibitors. Recombinate PUP Study Group.
    Nuss R, Jacobson L, Hathaway WE, Manco-Johnson M.
    Thromb Haemost; 1999 Nov; 82(5):1559-60. PubMed ID: 10595659
    [No Abstract] [Full Text] [Related]

  • 2. Frequency of specific coagulation inhibitors and antiphospholipid antibodies in Tunisian haemophiliacs.
    Kraiem I, Hadhri S, El Omri H, Sassi R, Chaabani W, Ennabli S, Skouri H.
    Ann Biol Clin (Paris); 2012 Nov; 70(6):659-65. PubMed ID: 23207810
    [Abstract] [Full Text] [Related]

  • 3. A continuing challenge: treatment of hemophilic children with acquired factor VIII inhibitors.
    Bell BA.
    Am J Pediatr Hematol Oncol; 1993 Feb; 15(1):105-6. PubMed ID: 8447549
    [No Abstract] [Full Text] [Related]

  • 4. [Acquired autoantibodies against human factor VIII: a new case].
    Cailleux N, Levesque H, Courtois H, Borg JY.
    J Mal Vasc; 1996 Feb; 21(5):324-8. PubMed ID: 9026552
    [Abstract] [Full Text] [Related]

  • 5. Anti-factor VIII inhibitors and lupus anticoagulants in haemophilia A patients.
    Blanco AN, Cardozo MA, Candela M, Santarelli MT, Pérez Bianco R, Lazzari MA.
    Thromb Haemost; 1997 Apr; 77(4):656-9. PubMed ID: 9134638
    [Abstract] [Full Text] [Related]

  • 6. Factor VIII inhibitors: structure and function in autoantibody and hemophilia A patients.
    Hoyer LW, Scandella D.
    Semin Hematol; 1994 Apr; 31(2 Suppl 4):1-5. PubMed ID: 7524160
    [No Abstract] [Full Text] [Related]

  • 7. Diagnosis of factor VIII versus nonspecific inhibitors.
    Goldsmith JC.
    Semin Hematol; 1993 Apr; 30(2 Suppl 1):3-6. PubMed ID: 8480195
    [No Abstract] [Full Text] [Related]

  • 8. The treatment of acquired factor VIII inhibitors: worldwide experience with porcine factor VIII concentrate. International Acquired Hemophilia Study Group.
    Kessler CM, Ludlam CA.
    Semin Hematol; 1993 Apr; 30(2 Suppl 1):22-7. PubMed ID: 8480193
    [No Abstract] [Full Text] [Related]

  • 9. Relationship between factor VIII mutation type and inhibitor development in a cohort of previously untreated patients treated with recombinant factor VIII (Recombinate). Recombinate PUP Study Group.
    Goodeve AC, Williams I, Bray GL, Peake IR.
    Thromb Haemost; 2000 Jun; 83(6):844-8. PubMed ID: 10896236
    [Abstract] [Full Text] [Related]

  • 10. [Hemophilia A with inhibitor].
    Takahashi I.
    Ryoikibetsu Shokogun Shirizu; 1998 Jun; (21 Pt 2):498-501. PubMed ID: 9833554
    [No Abstract] [Full Text] [Related]

  • 11. Coexistence of lupus anticoagulant and acquired haemophilia in a patient with monoclonal gammopathy of unknown significance.
    Taher A, Abiad R, Uthman I.
    Lupus; 2003 Jun; 12(11):854-6. PubMed ID: 14667103
    [Abstract] [Full Text] [Related]

  • 12. [Immune coagulation disorders (excluding antiphospholipid syndrome].
    Arai M.
    Rinsho Byori; 2001 Oct; 49(10):1000-4. PubMed ID: 11769464
    [Abstract] [Full Text] [Related]

  • 13. [Acquired factor VIII hemophilia in a geriatric patient].
    Boddi W, Machetti S, Sodi N, Sammicheli L, Cati G, Marotta G, Sabatini L, Cappelli R.
    Ann Ital Med Int; 2005 Oct; 20(3):192-6. PubMed ID: 16250186
    [Abstract] [Full Text] [Related]

  • 14. Non-parallelism in the one-stage coagulation factor assay is a phenomenon of lupus anticoagulants and not of individual factor inhibitors.
    Ruinemans-Koerts J, Peterse-Stienissen I, Verbruggen B.
    Thromb Haemost; 2010 Nov; 104(5):1080-2. PubMed ID: 20806127
    [No Abstract] [Full Text] [Related]

  • 15. [Determination of coagulation factor VIII inhibitors].
    Lutze G, Schlote A, Mittler U.
    Z Gesamte Inn Med; 1980 Apr 15; 35(8):330-6. PubMed ID: 6776700
    [Abstract] [Full Text] [Related]

  • 16. Simultaneous occurrence of lupus anticoagulant and factor VIII inhibitors.
    Triplett DA.
    Am J Hematol; 1997 Nov 15; 56(3):195-6. PubMed ID: 9371538
    [No Abstract] [Full Text] [Related]

  • 17. World registry on factor VIII inhibitor patients: why?
    Aledort LM.
    Semin Hematol; 1993 Apr 15; 30(2 Suppl 1):7-9. PubMed ID: 8480198
    [No Abstract] [Full Text] [Related]

  • 18. [Application of the plasma-agarose gel diffusion method to the detection and measurement of anti-Factor-VIII:C and other inhibitors of coagulation].
    Jorquera JI, Carmona E, Aznar JA, Cañada M, Peiró A, Sánchez-Cuenca JM.
    Sangre (Barc); 1985 Apr 15; 30(4-A):411-6. PubMed ID: 2416066
    [No Abstract] [Full Text] [Related]

  • 19. Factor VIII inhibitors in previously treated hemophilic patients.
    Mannucci PM.
    J Thromb Haemost; 2011 Nov 15; 9(11):2328-9. PubMed ID: 21929691
    [No Abstract] [Full Text] [Related]

  • 20. The effect of naturally occurring antibodies to factor VIII on an immunoradiometric assay for factor VIII coagulant antigen. Observation on a cross-reacting material-positive (CRM+) hemophiliac with a factor VIII inhibit.
    Brown JE, Carton CL, Hougie C.
    J Lab Clin Med; 1981 Jan 15; 97(1):65-71. PubMed ID: 6778942
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.